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ABSTRACT
Background and purpose The aim of this study was to
assess the long term outcome after non-aneurysmal
subarachnoid haemorrhage (SAH).
Methods 1154 patients with SAH were treated in our
hospital between 1989 and 1999. From this patient
population, 97 patients had a non-aneurysmal SAH. All
hospital records and death certiﬁcates were studied and
33 patients were examined by MRI and MR angiography
more than 9 years (mean 12 years) after the initial
bleeding.
Results The cohort consisted of 97 patients. Mean
follow-up time was 9 years (range 0e19). During the
follow-up period, 13 patients (13%) died. Four (4%) died
from the initial bleeding less than 5 weeks after the initial
haemorrhage. There was no delayed mortality due to
SAH or subsequent bleedings. MR angiography revealed
no new ﬁndings in 33 surviving patients.
Conclusions Excess mortality during the ﬁrst year after
SAH was higher than 4%, and remained thereafter
comparable with the general population. There were no
rebleedings and MR imaging did not reveal any vascular
pathology that could explain the earlier SAH.
INTRODUCTION
On average, in 15% (5e30%) of patients with
spontaneous subarachnoid haemorrhage (SAH), no
obvious source of bleeding can be demonstrated,
even with high quality four vessel cerebral digital
subtraction angiography (DSA).
1e8 The cause of
angiogram negative SAH has not been established
but a venous or capillary source, ruptured perfo-
rating artery, low ﬂow vascular malformation and
short segment arterial dissection have all been
postulated.
9e11 Some researchers do not accept this
and speculate that spontaneous thrombosis, vaso-
spasm, destruction of the aneurysm by haemor-
rhage, narrowing of the aneurysmal neck,
alterations in blood ﬂow, inadequate angiographic
technique or observer error may be responsible.
2
Outcome of angiogram negative SAH is good in
90% of cases.
4781 21 3However, many groups
report non-speciﬁc symptoms such as headache,
neuropsychological deﬁcits or depressive symptoms
in up to 62% of patients.
14e16 The rebleeding rate is
approximately 5% (0e10%)
781 5 e18 and the risk of
death in non-aneurysmal bleeding has been esti-
mated to be 0e15%
24781 21 31 51 71 8Greebe and
Rinkel
15 concluded that patients with an angio-
graphic negative perimesencephalic pattern of SAH
have a normal life expectancy but Hawkins et al
17
found the cumulative proportional survival after
22 years to be 69% compared with an expected
survival of 89% in patients with SAH of unknown
aetiology.
T ot h eb e s to fo u rk n o w l e d g et h e r ea r en os t u d i e s
analysing intracranial arterial status very long after
initial bleeding or that have reported the incidence of
de novo aneurysms in patients having SAH of
unknown aetiology. The aim of this study was to
assess long term outcome after non-aneurysmal SAH.
METHODS
Patients
Our hospital serves as a primary and secondary care
centre for patients with SAH, with a catchment
area of more than 1 million. Between 1989 and
1999, a total of 1154 patients with symptoms and
signs of spontaneous, non-traumatic SAH were
admitted to our hospital. Of these, 97 (8.4%)
patients were included in the study because the
aetiology of the SAH could not be veriﬁed by
repeated four vessel cerebral angiography or post-
mortem examination. SAH was diagnosed by CT
in 80 (82%) cases and by a blood positive lumbar
puncture in 17 (18%) cases. The diagnosis ‘SAH
NOS’ was based on DSA in 96 patients and post-
mortem examination in one patient. All hospital
records were studied and the latest outcome of
patients was evaluated from the most recent notes
in the hospital records or by telephone interview.
Clinical status at the time of the bleeding was
assessed according to the Hunt and Hess scale.
19
Glasgow Outcome Scale (GOS)
20 was used to
evaluate clinical status at the time of discharge
and at follow-up visits. Primary CT images were
re-evaluated to assess Fisher grades and the presence
of hydrocephalus. All angiograms were reviewed
independently by a neuroradiologist, neuro-
interventionalist and neurosurgeon. Thereafter, the
results were reviewed and a consensus statement
for each study was produced. Surviving patients
resident in our hospital catchment area were
contacted, offered an MRI examination and inter-
viewed to assess clinical outcome and possible
rebleeding episodes. A total of 33 were studied with
MRI and MR angiography (MRA), and interviewed
at our outpatient clinic. Follow-up MRI and MRA
were compared with the ﬁndings of earlier studies.
Surviving patients not studied with MRI lived
outside our hospital catchment area, did not
answer our letter, were unwilling to participate in
the study or had contraindications to MRI. Two
surviving patients were lost to clinical follow-up.
Thirteen of 97 patients died, and death certiﬁcates
were obtained from Statistics Finland. The study
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The follow-up MR imaging was performed with the 1.5 Tunit
(GE Signa HD, Milwaukee, USA) with one channel head coil.
MRA was supplemented with cross sectional imaging, including
ﬂuid attenuation inversion recovery, and T1 and T2* sequences,
mainly to identify ischaemic parenchyma, ascertain the size of
the CSF spaces and persisting blood degradation deposits. The
imaging parameters for the non-contrast three-dimensional time
of ﬂight angiography were: TR 30, TE 2.5, FOV 22316.5 cm, slice
thickness 1.0 mm/interpolated to 0.5 mm, matrix 3203224.
Magnetisation transfer contrast and ﬂow compensation were
included.
Statistical analysis
Statistical analysis was performed using NCSS (NCSS, Kays-
ville, Utah, USA) statistical software. Categorical variables were
compared using the Fisher exact two tailed test. The level of
signiﬁcance was set at p<0.05. Excess mortality of the patients
was measured by one relative survival ratio. The relative survival
ratio is the ratio of the actuarial observed survival rate divided by
expected survival rate of a comparable group of patients from
the Finnish general population matched by sex, age and calendar
time. Relative survival measures the survival experience of the
patients corrected for competing risks of death. Relative survival
ratios were estimated by survival package SURV3 V.3.01
(Finnish Cancer Registry, Helsinki, Finland).
RESULTS
Patients were aged 21e76 years (mean 52) at the time of
bleeding. There were 35 men and 62 women. Most patients had
a good clinical status on admission (table 1). In the deceased
group, patients had a poorer clinical status and higher Fisher
grades on primary CTcompared with the surviving group. There
was no other statistically signiﬁcant difference between the
surviving and deceased groups.
Thirteen of 97 patients (13%) died during the 868 patient-year
follow-up period. Four (4%) died from the initial bleeding of the
non-aneurysmal SAH: two immediately and two patients in
1 month after a poor clinical state. All four patients had severe
bleeding on the initial CT (Fisher 3 or 4, non-perimesencephalic
type of bleeding). Three patients died of cardiovascular diseases,
three of malignancies and three due to traumatic causes.
Mortality in the ﬁrst year after bleeding was more than 4% in
excess of that expected in a comparable group from the general
population, both among women and men. Thereafter, mortality
of the patients was close to the level in the general population.
There were no rebleedings. Ninety-four per cent of the surviving
group (79/84) had recovered well (GOS 4 or 5) and the reason for
the lower GOS was related to SAH in only two (2%) patients
(ﬁgure 1). There was no difference in outcome between patients
studied with and without MRI.
Thirty-three patients were studied with MRI. Mean follow-up
time was 12 years (range 9e18). No new aneurysms were
detected in MRA images or any other vascular pathology that
could explain the previous bleeding. Six patients (18%) had
infarctions in MRI. Two were already seen during the treatment
period after clinically and radiologically proven vasospasm. Four
infarctions were not detected in earlier images and only two of
those four patients had been treated for clinical stroke.
Leukoaraiosis was seen in 11 (34%) patients. Signs of superﬁcial
haemosiderin were present in two patients (6%).
DISCUSSION
After SAH, initial angiographic ﬁndings are negative for
a bleeding source in approximately 15% of patients.
1e8 A
traditional concept states that angiogram negative SAH carries
a more benign prognosis than aneurysmal SAH. However, some
patients experience morbidity and mortality because of recur-
rent haemorrhage or vasospasm.
14 21e23 Repeat DSA within
2 weeks after the bleeding is commonly performed. Although
repeat DSA provides identiﬁcation of the source of bleeding in
up to 20% of cases, the source remains undetected in the
majority of patients.
22e24 The incidence of angiogram negative
SAH was 8.4% in our series and this concurs with recent
series.
1e8
We found no new arterial vasculopathies or other aetiologies for
previous SAH in those 33 patients studied. It is a weakness of our
study that we performed MRI in only 34% of patients. However,
those surviving patients we could not reach had a poorer clinical
status and we believe that this selection bias is unlikely to inﬂu-
ence the MRI ﬁndings. Infarctions were detected in six (18%)
patients, which is signiﬁcantly less than in patients with aneu-
rysmal SAH.
25e27 Two infarctions were caused by vasospasm and
Table 1 Population characteristics
Surviving group (n[84) Deceased group (n[13)

























GOS, Glasgow Outcome Score.
Figure 1 Present Glasgow Outcome Score (GOS) of patients with
subarachnoid haemorrhage of unknown aetiology.
J Neurol Neurosurg Psychiatry 2011;82:1264e1266. doi:10.1136/jnnp.2010.239335 1265
Research papertwo were incidental ﬁndings. Leukoaraiosis was seen in 11 (34%)
patients and this was less than in aneurysmal SAH patients and
not more than the prevalence in a neurologically health age
cohort.
25e28 Earlier studies of angiogram negative SAH have
reported a subsequent bleeding rate of up to 10%.
7 8 17 18 29
However, the latest reports have detected no rebleedings and
neither did we.
15 16
The outcome is much better in SAH patients with unknown
aetiology than in aneurysmal SAH patients.
2 4781 21 31 51 71 8
Eighty-one per cent of patients had recovered well (GOS 4 or 5)
and poor outcome was related to SAH in only six (6%) patients
in our series. The risk of death from non-aneurysmal bleeding
has been estimated to be 0e15%.
24781 21 31 51 71 8In our series,
4% of patients died of angiogram negative SAH. Overall
mortality in our series was 13% compared with 47% mortality
in aneurysmal SAH patients in our hospital at the same time.
30
In the long term outcome study, patients with SAH of unknown
cause had reduced life expectancy compared with expected
numbers.
17 However, in that study, as many as 22% of all SAH
patients had no cause on angiogram, which was not repeated,
raising the suspicion that aneurysms were missed. Greebe and
Rinkel,
15 however, found no difference in mortality between the
general population and patients with a perimesencephalic
pattern of non-aneurysmal SAH. This study was, however,
involved only a subgroup of all patients with SAH of unknown
aetiology and to the best of our knowledge our study is the only
one in the modern imaging modality era to assess the long term
outcome of patients with SAH of unknown aetiology.
CONCLUSION
Excess mortality during the ﬁrst year after SAH was higher
than 4%, and remained thereafter comparable with the general
population. There were no rebleedings and MR imaging did not
reveal any vascular pathology that could explain the previous
SAH. Based on our results, long term follow-up is not needed,
and after appropriate angiographic studies, patients should be
informed about the benign nature of this rare type of SAH.
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